{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36872974", "DateRevised": {"Year": "2023", "Month": "03", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.2c07951"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "8", "Issue": "8", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "28"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Antiamnesic Effects of Novel Phthalimide Derivatives in Scopolamine-Induced Memory Impairment in Mice: A Useful Therapy for Alzheimer's Disease.", "Pagination": {"StartPage": "8052", "EndPage": "8065", "MedlinePgn": "8052-8065"}, "Abstract": {"AbstractText": ["Phthalimides have diverse bioactivities and are attractive molecules for drug discovery and development. Here, we explored new synthesized phthalimide derivatives (compounds <b>1</b>-<b>3</b>) in improving memory impairment associated with Alzheimer's disease (AD), using <i>in vitro</i> and <i>ex vivo</i> acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition and <i>in vivo</i> models, including Y-maze test and novel object recognition test (NORT). Compounds <b>1</b>-<b>3</b> exhibited significant AChE activity with IC<sub>50</sub> values of 10, 140, and 18 \u03bcM and BuChE with IC<sub>50</sub> values of 80, 50, and 11 \u03bcM, respectively. All compounds <b>1</b>-<b>3</b> showed excellent antioxidant potential in DPPH and ABTS assays with IC<sub>50</sub> values in the range of 105-340 and 205-350 \u03bcM, respectively. In <i>ex vivo</i> studies, compounds <b>1</b>-<b>3</b> also significantly inhibited both enzymes in a concentration-dependent manner along with significant antioxidant activities. In <i>in vivo</i> studies, compounds <b>1</b>-<b>3</b> reversed scopolamine-induced amnesia as indicated by a significant increase in the spontaneous alternation in the Y-maze test and an increase in the discrimination index in the NORT. Molecular docking was also conducted for compounds <b>1</b>-<b>3</b> against AChE and BuChE, which showed that compounds <b>1</b> and <b>3</b> have excellent binding with AChE and BuChE as compared to <b>2</b>. These findings suggest that compounds <b>1</b>-<b>3</b> possess significant antiamnesic potential and may serve as useful leads to develop novel therapeutics for the symptomatic management and treatment of AD."], "CopyrightInformation": "\u00a9 2023 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": ["0000-0002-1087-4241"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Peshawar, Peshawar 25120, KPK, Pakistan."}], "LastName": "Karim", "ForeName": "Nasiara", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Peshawar, Peshawar 25120, KPK, Pakistan."}], "LastName": "Khan", "ForeName": "Inbisat", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Swabi, Swabi 23430, KPK, Pakistan."}], "LastName": "Khan", "ForeName": "Imran", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz 616, Nizwa 616, Oman."}], "LastName": "Halim", "ForeName": "Sobia Ahsan", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box 114, Jazan 45142, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, P.O. Box 2404, Khartoum 11115, Sudan."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": ["0000-0003-4770-9319"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Abdalla", "ForeName": "Ashraf N", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz 616, Nizwa 616, Oman."}], "LastName": "Rehman", "ForeName": "Najeeb Ur", "Initials": "NU"}, {"Identifier": ["0000-0001-7851-6080"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz 616, Nizwa 616, Oman."}], "LastName": "Khan", "ForeName": "Ajmal", "Initials": "A"}, {"Identifier": ["0000-0002-0815-5942"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz 616, Nizwa 616, Oman."}], "LastName": "Al-Harrasi", "ForeName": "Ahmed", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dharmarajan T. S.; Gunturu S. G. Alzheimer\u2019s disease: a healthcare burden of epidemic proportion. Am. Health Drug Benefits 2009, 2, 39\u201347.", "ArticleIdList": ["PMC4106591", "25126271"]}, {"Citation": "Elmaidomy A. H.; Abdelmohsen U. R.; Alsenani F.; Aly H. F.; Shams S. G. E.; Younis E. A.; Ahmed K. A.; Sayed A. M.; Owis A. I.; Afifi N.; et al. The anti-Alzheimer potential of Tamarindus indica: an in vivo investigation supported by in vitro and in silico approaches. RSC Adv. 2022, 12, 11769\u201311785. 10.1039/D2RA01340A.", "ArticleIdList": ["10.1039/D2RA01340A", "PMC9015909", "35481086"]}, {"Citation": "Qiu C.; Kivipelto M.; von Strauss E. Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin. Neurosci. 2009, 11, 111\u2013128. 10.31887/DCNS.2009.11.2/cqiu.", "ArticleIdList": ["10.31887/DCNS.2009.11.2/cqiu", "PMC3181909", "19585947"]}, {"Citation": "Wong W. Economic burden of Alzheimer disease and managed care considerations. Am. J. Managed Care 2020, 26, S177\u2013S183. 10.37765/ajmc.2020.88482.", "ArticleIdList": ["10.37765/ajmc.2020.88482", "32840331"]}, {"Citation": "Scarmeas N.; Brandt J.; Albert M.; Hadjigeorgiou G.; Papadimitriou A.; Dubois B.; Sarazin M.; Devanand D.; Honig L.; Marder K.; Bell K.; Wegesin D.; Blacker D.; Stern Y. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch. Neurol. 2005, 62, 1601\u20138. 10.1001/archneur.62.10.1601.", "ArticleIdList": ["10.1001/archneur.62.10.1601", "PMC3028538", "16216946"]}, {"Citation": "Zenebe Y.; Akele B.; M W. S.; Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann. Gen. Psychiatr. 2021, 20, 5510.1186/s12991-021-00375-x.", "ArticleIdList": ["10.1186/s12991-021-00375-x", "PMC8684627", "34922595"]}, {"Citation": "Tanzi R. E. The genetics of Alzheimer disease. Cold Spring Harbor Perspect. Med. 2012, 2, a00629610.1101/cshperspect.a006296.", "ArticleIdList": ["10.1101/cshperspect.a006296", "PMC3475404", "23028126"]}, {"Citation": "Van Broeckhoven C. L. Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur. Neurol. 1995, 35, 8\u201319. 10.1159/000117083.", "ArticleIdList": ["10.1159/000117083", "7737252"]}, {"Citation": "Barnes D. E.; Yaffe K. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 2011, 10, 819\u2013828. 10.1016/S1474-4422(11)70072-2.", "ArticleIdList": ["10.1016/S1474-4422(11)70072-2", "PMC3647614", "21775213"]}, {"Citation": "Tarawneh R.; Holtzman D. M. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harbor Perspect. Med. 2012, 2, a00614810.1101/cshperspect.a006148.", "ArticleIdList": ["10.1101/cshperspect.a006148", "PMC3331682", "22553492"]}, {"Citation": "Castellani R. J.; Rolston R. K.; Smith M. A. Alzheimer disease. Disease-a-Month 2010, 56, 484\u2013546. 10.1016/j.disamonth.2010.06.001.", "ArticleIdList": ["10.1016/j.disamonth.2010.06.001", "PMC2941917", "20831921"]}, {"Citation": "Perez S. E.; Raghanti M. A.; Hof P. R.; Kramer L.; Ikonomovic M. D.; Lacor P. N.; Erwin J. M.; Sherwood C. C.; Mufson E. J. Alzheimer\u2019s disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla). J. Comp. Neurol. 2013, 521, 4318\u20134338. 10.1002/cne.23428.", "ArticleIdList": ["10.1002/cne.23428", "PMC6317365", "23881733"]}, {"Citation": "Kalaria R. N.; Maestre G. E.; Arizaga R.; Friedland R. P.; Galasko D.; Hall K.; Luchsinger J. A.; Ogunniyi A.; Perry E. K.; Potocnik F.; Prince M.; Stewart R.; Wimo A.; Zhang Z. X.; Antuono P. Alzheimer\u2019s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008, 7, 812\u201326. 10.1016/S1474-4422(08)70169-8.", "ArticleIdList": ["10.1016/S1474-4422(08)70169-8", "PMC2860610", "18667359"]}, {"Citation": "Sharma U.; Kumar P.; Kumar N.; Singh B. Recent advances in the chemistry of phthalimide analogues and their therapeutic potential. Mini Rev. Med. Chem. 2010, 10, 678\u2013704. 10.2174/138955710791572442.", "ArticleIdList": ["10.2174/138955710791572442", "20402635"]}, {"Citation": "Aliabadi A.; Foroumadi A.; Mohammadi-Farani A.; Garmsiri Mahvar M. Synthesis and Evaluation of Anti-acetylcholinesterase Activity of 2-(2-(4-(2-Oxo-2-phenylethyl)piperazin-1-yl) ethyl)Isoindoline-1,3-dione Derivatives with Potential Anti-Alzheimer Effects. Iran. J. Basic Med. Sci. 2013, 16, 1049\u20131054.", "ArticleIdList": ["PMC3874090", "24379961"]}, {"Citation": "Alonso D.; Dorronsoro I.; Rubio L.; Mu\u00f1oz P.; Garc\u00eda-Palomero E.; Del Monte M.; Bidon-Chanal A.; Orozco M.; Luque F. J.; Castro A.; Medina M.; Mart\u00ednez A. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE. Bioorg. Med. Chem. 2005, 13, 6588\u20136597. 10.1016/j.bmc.2005.09.029.", "ArticleIdList": ["10.1016/j.bmc.2005.09.029", "16230018"]}, {"Citation": "Karim N.; Khan I.; Abdelhalim A.; Abdel-Halim H.; Hanrahan J. R. Molecular docking and antiamnesic effects of nepitrin isolated from Rosmarinus officinalis on scopolamine-induced memory impairment in mice. Biomed. Pharmacother. 2017, 96, 700\u2013709. 10.1016/j.biopha.2017.09.121.", "ArticleIdList": ["10.1016/j.biopha.2017.09.121", "29040957"]}, {"Citation": "Kostelnik A.; Pohanka M. Inhibition of Acetylcholinesterase and Butyrylcholinesterase by a Plant Secondary Metabolite Boldine. BioMed Res. Int. 2018, 2018, 963434910.1155/2018/9634349.", "ArticleIdList": ["10.1155/2018/9634349", "PMC5907398", "29850593"]}, {"Citation": "Abdelhalim A.; Karim N.; Chebib M.; Aburjai T.; Khan I.; Johnston G. A.; Hanrahan J. Antidepressant, Anxiolytic and Antinociceptive Activities of Constituents from Rosmarinus Officinalis. J. Pharm. Pharm. Sci. 2015, 18, 448\u2013459. 10.18433/J3PW38.", "ArticleIdList": ["10.18433/J3PW38", "26626245"]}, {"Citation": "Jothy S. L.; Zakaria Z.; Chen Y.; Lau Y. L.; Latha L. Y.; Sasidharan S. Acute oral toxicity of methanolic seed extract of Cassia fistula in mice. Molecules 2011, 16, 5268\u20135282. 10.3390/molecules16065268.", "ArticleIdList": ["10.3390/molecules16065268", "PMC6264368", "21701437"]}, {"Citation": "Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968, 13, 222\u2013257. 10.1007/BF00401402.", "ArticleIdList": ["10.1007/BF00401402", "5679627"]}, {"Citation": "Ashwini G.; Pranay P.; Thrinath G.; Karnaker Reddy T.; Giri Prasad V. Pharmacological evalution of Marsilea qudrifolia plant extracts against Alzheimer\u2019s disease. Int. J. Drug Dev. Res. 2012, 4, 153\u2013158."}, {"Citation": "Hughes R. N. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci. Biobehav. Rev. 2004, 28, 497\u2013505. 10.1016/j.neubiorev.2004.06.006.", "ArticleIdList": ["10.1016/j.neubiorev.2004.06.006", "15465137"]}, {"Citation": "Konrath E. L.; Neves B. M.; Lunardi P. S.; Passos Cdos S.; Sim\u00f5es-Pires A.; Ortega M. G.; Gon\u00e7alves C. A.; Cabrera J. L.; Moreira J. C.; Henriques A. T. Investigation of the in vitro and ex vivo acetylcholinesterase and antioxidant activities of traditionally used Lycopodium species from South America on alkaloid extracts. J. Ethnopharmacol. 2012, 139, 58\u201367. 10.1016/j.jep.2011.10.042.", "ArticleIdList": ["10.1016/j.jep.2011.10.042", "22108682"]}, {"Citation": "Deiana S.; Platt B.; Riedel G. The cholinergic system and spatial learning. Behav. Brain Res. 2011, 221, 389\u2013411. 10.1016/j.bbr.2010.11.036.", "ArticleIdList": ["10.1016/j.bbr.2010.11.036", "21108971"]}, {"Citation": "Daulatzai M. A. Early Stages of Pathogenesis in Memory Impairment during Normal Senescence and Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 2010, 20, 355\u2013367. 10.3233/JAD-2010-1374.", "ArticleIdList": ["10.3233/JAD-2010-1374", "20164576"]}, {"Citation": "Swerdlow R. H. Pathogenesis of Alzheimer\u2019s disease. Clin. Interventions Aging 2007, 2, 347\u201359.", "ArticleIdList": ["PMC2685260", "18044185"]}, {"Citation": "Lueptow L. M. Novel Object Recognition Test for the Investigation of Learning and Memory in Mice. J. Vis. Exp. 2017, 126, e5571810.3791/55718.", "ArticleIdList": ["10.3791/55718", "PMC5614391", "28892027"]}, {"Citation": "Iwashita H.; Sano M.; Chiba A. Diazepam induces retrograde facilitation of object recognition and object location memory in male mice. NeuroReport 2023, 34, 10-109710.1097/WNR.0000000000001869.", "ArticleIdList": ["10.1097/WNR.0000000000001869", "36574287"]}, {"Citation": "Sang Z.; Wang K.; Wang H.; Yu L.; Wang H.; Ma Q.; Ye M.; Han X.; Liu W. Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer\u2019s disease. Bioorg. Med. Chem. Lett. 2017, 27, 5053\u20135059. 10.1016/j.bmcl.2017.09.055.", "ArticleIdList": ["10.1016/j.bmcl.2017.09.055", "29033232"]}, {"Citation": "Soyer Z.; Uysal S.; Parlar S.; Tarikogullari Dogan A. H.; Alptuzun V. Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. J. Enzyme Inhib. Med. Chem. 2017, 32, 13\u201319. 10.1080/14756366.2016.1226298.", "ArticleIdList": ["10.1080/14756366.2016.1226298", "PMC6009942", "27766908"]}, {"Citation": "Mohammadi-Farani A.; Ahmadi A.; Nadri H.; Aliabadi A. Synthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-Benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects. DARU, J. Pharm. Sci. 2013, 21, 4710.1186/2008-2231-21-47.", "ArticleIdList": ["10.1186/2008-2231-21-47", "PMC3704662", "23758724"]}, {"Citation": "Bag S.; Tulsan R.; Sood A.; Cho H.; Redjeb H.; Zhou W.; LeVine H.; T\u00f6r\u00f6k B.; T\u00f6r\u00f6k M. Sulfonamides as multifunctional agents for Alzheimer\u2019s disease. Bioorg. Med. Chem. Lett. 2015, 25, 626\u2013630. 10.1016/j.bmcl.2014.12.006.", "ArticleIdList": ["10.1016/j.bmcl.2014.12.006", "25537270"]}, {"Citation": "Akin Kazancioglu E.; Senturk M. Synthesis of N-phenylsulfonamide derivatives and investigation of some esterase enzymes inhibiting properties. Bioorg. Chem. 2020, 104, 10427910.1016/j.bioorg.2020.104279.", "ArticleIdList": ["10.1016/j.bioorg.2020.104279", "32980674"]}, {"Citation": "Galasko D. R.; Peskind E.; Clark C. M.; Quinn J. F.; Ringman J. M.; Jicha G. A.; Cotman C.; Cottrell B.; Montine T. J.; Thomas R. G.; Aisen P. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 2012, 69, 836\u2013841. 10.1001/archneurol.2012.85.", "ArticleIdList": ["10.1001/archneurol.2012.85", "PMC3661272", "22431837"]}, {"Citation": "Karthik C. S.; Mallesha L.; Mallu P. Investigation of Antioxidant Properties of Phthalimide Derivatives. Can. Chem. Trans. 2015, 3, 199\u2013206. 10.13179/canchemtrans.2015.03.02.0194.", "ArticleIdList": ["10.13179/canchemtrans.2015.03.02.0194"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "14"}, {"Year": "2023", "Month": "2", "Day": "6"}, {"Year": "2023", "Month": "3", "Day": "6", "Hour": "3", "Minute": "35"}, {"Year": "2023", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["36872974", "PMC9979339", "10.1021/acsomega.2c07951"]}}], "PubmedBookArticle": []}